Angela Woodall
Angela Woodall is a freelance journalist based in the San Francisco Bay Area. She covers health care policy, devices, biotech and clinical trials. She is a former Oakland Tribune reporter whose independent work has appeared in Al Jazeera America, London Guardian, More Magazine, The Globalist, Agence France-Presse, The California Health Report and other publications.
-
Research consortium building scaffolding for Precision Medicine Initiative’s All of Us
Last week, the National Institutes of Health, which is heading the initiative, rebranded the Precision Medicine Initiative’s cohort program as “All of Us.”
-
Devices & Diagnostics, Startups
Child prodigy’s approach to diagnosing concussions nabs spot in pediatric medical device contest
Averia, co-founded by Rohan Suri, has developed a way to diagnose concussions which combines an iPhone, an app and a cardboard headset.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Protein-motion startup launches armed with $57M to develop drugs, crack cancer code
Relay Therapeutics is aiming to identify the way proteins in cells move and shift and morph, and this understanding can help open the door to new, more effective drugs.
-
UPMC backs cancer diagnostics startup Cernostics
Cernostics is part of the wave of oncology that looks at cancer at the tissue and cellular level instead of focusing on the location of the tumor — lung, stomach, pancreas.
-
Startup Spirometrix readies connected asthma sensors for market
Spirometrix wants to see nearly 20 percent of pulmonologists and allergists using the Fenom Pro sensor by 2020.
-
Chinese-backed developer gets OK for $1B biotech campus on SF Bay
An initial $300 million injection will set the development in motion and by 2021, the entire 2.25 million square-foot site is expected to be developed.
-
New partnerships aims to unlock mysteries of traumatic brain injury
Quanterix and Banyan Biomarkers want to study two proteins about which not much is known but that show up in the blood when humans take a blow to their head.
-
After $371M merger, what comes next for LabCorp and Sequenom?
The two companies are perched on a risky, competitive genetic testing market valued in 2015 at $3 billion.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
This telemed app aims to replace the patient visit entirely
SmartExam from Bright.MD is being adopted in places like the Rush University Medical Center to replace in-person routine care with telemedicine so the focus can be on sicker patients.
-
Health data should belong to patients, Topol argues
What constitutes health data is no longer so easily defined. Neither is how the information is used.
-
Bristol Myers’ small deal underscores how hot immuno-oncology is
BMS’ purchase of Cormorant shows that no deal is too small when it comes to immuno-oncology.
-
5 takeaways from Bioventus IPO move
Bioventus develops orthopedic products designed to treat conditions affecting muscles, bones and joints. Its top sellers include a therapy for fractures and osteoarthritis,
-
Emerge Diagnostics raises fresh capital to detect injuries in workers compensation industry
Emerge Diagnostics entered the tumultuous workers compensation industry four years ago with a device able to detect the kind of workplace injuries that cost employers millions of dollars annually, but are the hardest to spot.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
